Stock
Shares of Oxford Industries (NASDAQ: OXM) jumped more than 26% on Thursday after the apparel retailer reported second-quarter results that exceeded analysts’ earnings expectations,...
Connect with us
Hi, what are you looking for?
Your Next Gen Investing
Stock
Following a meeting with US Energy Secretary Chris Wright, EU Energy Commissioner Dan Jorgensen stated on Thursday that the EU remains committed to its...
Stock
The QQQ ETF continued its strong rally, a trend that may continue on Wednesday after Oracle published strong financial results. The fund, which tracks...
Stock
US equities could climb another 20% by the end of 2026, fueled by what strategists at Evercore ISI describe as a transformative wave of...
Stock
Across Europe, frustration over soaring executive pay and government austerity has been boiling over into strikes, protests, and even shareholder revolts. By September 2025,...
Stock
The Dow Jones, S&P 500, and Nasdaq 100 indices and their ETFs moved sideways last week as investors focused on monetary policy and Nvidia...
Stock
Marvell stock price plummeted by over 18% on Friday after the semiconductor giant published its earnings report. MRVL plunged to a low of $62.87,...
Stock
Retail stocks have done fairly well since April, as indicated by the “XRT” exchange-traded fund (ETF). Still, R5 Capital founder Scott Mushkin says the...
Stock
The IPO season is here, with several companies like Circle, CoreWeave, Bullish, Webull, and eToro already public. The Klarna IPO, which may come as...
Stock
Ambarella (NASDAQ: AMBA) stock soared 20% on Friday after the semiconductor company delivered second-quarter earnings that topped Wall Street expectations and issued guidance well...
Stock
Lululemon stock price has moved from being one of the most beloved into a fallen angel, a trend that may continue after Gap, its...
Stock
Offline oil refining capacity in Russia reached a record high in August due to damage from Ukrainian drone attacks and extensive planned maintenance, according...
Stock
Shares of Outlook Therapeutics fell sharply on Thursday after the US Food and Drug Administration (FDA) rejected the company’s application for its experimental eye...
